article thumbnail

Desperate Measures: Ghaemi’s Response to Our Review of Lithium and Suicide Prevention

Mad in America

Moncrieff, 2008 ; Moncrieff, 2018 ). But Ghaemi wants to claim that lithium is special—that it does more than target symptom mechanisms, it modifies the disease process that underpins bipolar disorder. Ghaemi thinks glutamate is the culprit in schizophrenia, however, which is unaffected by antipsychotics ( Ghaemi, 2022 ).

article thumbnail

Mood Tracking: My System for Reducing Psychiatric Hospitalizations

Mad in America

I was first diagnosed with bipolar disorder in 1998. Shortly after the article was published, and the break-up occurred, I was hospitalized and diagnosed as bipolar. From 2001 to 2008, I was hospitalized for mania at a rate of almost once per year (7 times in 8 years)—including one month-long hospitalization.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

For-Profit Healthcare Is a Predator; Its Main Prey Is Our Young

Mad in America

But now they often say Since they have bipolar disorder, theyll never be able to manage their emotions or achieve any stability. 2008 Sep 25;2;26. Parents of volatile teenagers used to say This is hard, but Ill be patient, since I know its a phase they must go through in order to develop into competent, independent adults.

article thumbnail

Could IPT Be a Treatment Option for Autism?

International Society for Interpersonal Psychother

The ability to mentalize is a fundamental capacity required in our social environment and impairments may utilise a risk for clinical psychiatric disorders (A. Bateman & Fonagy, 2008). 2015) and borderline personality disorder (A. Diagnostic and statistical manual of mental disorders (4th ed.). Bateman, 2012).

article thumbnail

Why Failed Psychiatry Lives On: Its Industrial Complex, Politics, & Technology Worship

Mad in America

One of many psychiatrists exposed by 2008 Congressional hearings on psychiatry’s financial relationship with drug companies was Harvard psychiatrist Joseph Biederman—credited with creating pediatric bipolar disorder—who received $1.6 million in consulting fees from drug makers from 2000 to 2007.